FX-125L

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFX-125L
Drug Alias NameFX-125L
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCXC chemokine receptor antagonists
TargetsCXC chemokine receptor
Therapy Area/IndicationsInflammationAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFunxional Therapeutics (Fxt)
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgFunxional Therapeutics (Fxt)
Inactive CompaniesN/A
Active IndicationsInflammationAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A